CD4 <sup>+</sup> T cells contribute to neurodegeneration in Lewy body dementia

David Gate(Northwestern University), Emma Tapp(Neurosciences Institute), Olivia Leventhal(Neurosciences Institute), Marian Shahid(Stanford University), Tim J. Nonninger(Neurosciences Institute), Andrew C. Yang(Stanford University), Katharina Strempfl(Paracelsus Medical University), Michael S. Unger(Paracelsus Medical University), Tobias Fehlmann(Saarland University), Hamilton Oh(Neurosciences Institute), Divya Channappa(Stanford University), Victor W. Henderson(Stanford University), Andreas Keller(Saarland University), Ludwig Aigner(Paracelsus Medical University), Douglas Galasko(University of California San Diego), Mark M. Davis(Howard Hughes Medical Institute), Kathleen L. Poston(Stanford University), Tony Wyss‐Coray(Neurosciences Institute)
Science
October 15, 2021
Cited by 218Open Access
Full Text

Abstract

Autoimmunity in Lewy body dementia Lewy body dementia (LBD) is a brain disease that leads to progressive decline in thinking, movement, and independent function. It results from the build-up of microscopic deposits called Lewy bodies, which develop from the aggregation of a misfolded protein called α-synuclein. Gate et al . observed immune cells known as T cells in the brains of LBD patients (see the Perspective by Krot and Rolls). Genomics analysis revealed that T cells traffic to the LBD brain and are associated with neuronal damage. When stimulated with α-synuclein, LBD patient T cells secrete an inflammatory protein known to damage neurons. These findings suggest an unexpected detrimental role of the immune system in LBD. —SMH


Related Papers

No related papers found

Powered by citation graph analysis